Join the limbic in combination with HaemSTAR as Dr Mark Thomas discusses the evidence base behind decision-making for antithrombotic therapies and highlights a new approach that uses AI to guide clinicians through this increasingly complex field.

TOPICS COVERED

Dr Mark Thomas will give a 30 min presentation on the complexities of choosing antithrombitic therapies and the possible role of AI, followed by a 15 min Q&A session chaired by Dr Richard Buka.

WHO SHOULD ATTEND?

• Consultants
• Advanced Trainees in Haematology

SPEAKERS

• Dr Mark Thomas, Associate Professor of Cardiology and Honorary Consultant Cardiologist at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.
• Dr Richard Buka, Chair of HaemSTAR, and haematology registrar currently working on his PhD at the University of Birmingham.